 | • レポートコード：QFJ1-4119 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、糖尿病サプリメントの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビタミン、ミネラル、ハーブ、たんぱく質、食物繊維、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・糖尿病サプリメントの市場動向 ・企業の競争状況、市場シェア ・糖尿病サプリメントの種類別市場規模と予測2016-2027（ビタミン、ミネラル、ハーブ、たんぱく質、食物繊維、その他） ・糖尿病サプリメントの用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・糖尿病サプリメントの北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病サプリメントの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病サプリメントのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病サプリメントの中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病サプリメントの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novo Nordisk、Nestlé Health Science、Danone Nutricia、NaturoGain、Nature's Sunshine Forms、Nature's Bounty、Glucose Health, Inc、Unilever(Horlicks Cardia +)、Bionova Lifesciences、Caelus Health、Abbott、Pfizer、Arkopharma Laboratories、GlaxoSmithKline、Archer Daniels Midland、Herbalife International） ・結論 |
Diabetes, also known diabetes mellitus, is a metabolic disease resulting in high blood sugar. The hormone known as insulin is responsible for the movement of sugar from the blood into the cells, which is stored and used for providing energy to the body. In case of diabetes, body is either unable to produce enough insulin or cannot effectively utilize insulin produced Two main types of diabetes are type 1 diabetes and type 2 diabetes. In case of type 1 diabetes, the immune system attacks and destroys insulin producing cells in the pancreas while in type 2 diabetes patients the body becomes resistant to insulin. Dietary supplements are ingredients that are intended to enhance the diet of a person and contain vitamins, minerals, herbs, amino acids, metabolites, and other substances. These supplements are used for lowering blood glucose, improving cholesterol, lowering blood pressure, neuropathy, insulin resistance, and other complications in diabetic patients.
Market Analysis and Insights: Global Diabetes Supplements Market
The global Diabetes Supplements market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Supplements market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Supplements market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Supplements market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Supplements market.
Global Diabetes Supplements Scope and Market Size
Diabetes Supplements market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel in terms of revenue and forecast for the period 2016-2027.
Segment by Type
By Supplements Type
Vitamins
Minerals
Herbs
Proteins
Dietary Fibers
Others
By Dosage Form
Tablets
Capsules
Powders
Soft Gels
Liquids
Others
Segment by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novo Nordisk
Nestlé Health Science
Danone Nutricia
NaturoGain
Nature’s Sunshine Forms
Nature’s Bounty
Glucose Health, Inc
Unilever(Horlicks Cardia +)
Bionova Lifesciences
Caelus Health
Abbott
Pfizer
Arkopharma Laboratories
GlaxoSmithKline
Archer Daniels Midland
Herbalife International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Supplements Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vitamins
1.2.3 Minerals
1.2.4 Herbs
1.2.5 Proteins
1.2.6 Dietary Fibers
1.2.7 Others
1.3 Market by Application
1.3.1 Global Diabetes Supplements Market Share by Distribution Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Supplements Market Perspective (2016-2027)
2.2 Diabetes Supplements Growth Trends by Regions
2.2.1 Diabetes Supplements Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Supplements Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Supplements Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Supplements Industry Dynamic
2.3.1 Diabetes Supplements Market Trends
2.3.2 Diabetes Supplements Market Drivers
2.3.3 Diabetes Supplements Market Challenges
2.3.4 Diabetes Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Supplements Players by Revenue
3.1.1 Global Top Diabetes Supplements Players by Revenue (2016-2021)
3.1.2 Global Diabetes Supplements Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Supplements Revenue
3.4 Global Diabetes Supplements Market Concentration Ratio
3.4.1 Global Diabetes Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Supplements Revenue in 2020
3.5 Diabetes Supplements Key Players Head office and Area Served
3.6 Key Players Diabetes Supplements Product Solution and Service
3.7 Date of Enter into Diabetes Supplements Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Supplements Breakdown Data by Type
4.1 Global Diabetes Supplements Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Supplements Forecasted Market Size by Type (2022-2027)
5 Diabetes Supplements Breakdown Data by Distribution Channel
5.1 Global Diabetes Supplements Historic Market Size by Distribution Channel (2016-2021)
5.2 Global Diabetes Supplements Forecasted Market Size by Distribution Channel (2022-2027)
6 North America
6.1 North America Diabetes Supplements Market Size (2016-2027)
6.2 North America Diabetes Supplements Market Size by Type
6.2.1 North America Diabetes Supplements Market Size by Type (2016-2021)
6.2.2 North America Diabetes Supplements Market Size by Type (2022-2027)
6.2.3 North America Diabetes Supplements Market Size by Type (2016-2027)
6.3 North America Diabetes Supplements Market Size by Distribution Channel
6.3.1 North America Diabetes Supplements Market Size by Distribution Channel (2016-2021)
6.3.2 North America Diabetes Supplements Market Size by Distribution Channel (2022-2027)
6.3.3 North America Diabetes Supplements Market Size by Distribution Channel (2016-2027)
6.4 North America Diabetes Supplements Market Size by Country
6.4.1 North America Diabetes Supplements Market Size by Country (2016-2021)
6.4.2 North America Diabetes Supplements Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Diabetes Supplements Market Size (2016-2027)
7.2 Europe Diabetes Supplements Market Size by Type
7.2.1 Europe Diabetes Supplements Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Supplements Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Supplements Market Size by Type (2016-2027)
7.3 Europe Diabetes Supplements Market Size by Distribution Channel
7.3.1 Europe Diabetes Supplements Market Size by Distribution Channel (2016-2021)
7.3.2 Europe Diabetes Supplements Market Size by Distribution Channel (2022-2027)
7.3.3 Europe Diabetes Supplements Market Size by Distribution Channel (2016-2027)
7.4 Europe Diabetes Supplements Market Size by Country
7.4.1 Europe Diabetes Supplements Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Supplements Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Supplements Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Supplements Market Size by Type
8.2.1 Asia-Pacific Diabetes Supplements Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Supplements Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Supplements Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Supplements Market Size by Distribution Channel
8.3.1 Asia-Pacific Diabetes Supplements Market Size by Distribution Channel (2016-2021)
8.3.2 Asia-Pacific Diabetes Supplements Market Size by Distribution Channel (2022-2027)
8.3.3 Asia-Pacific Diabetes Supplements Market Size by Distribution Channel (2016-2027)
8.4 Asia-Pacific Diabetes Supplements Market Size by Region
8.4.1 Asia-Pacific Diabetes Supplements Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Supplements Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Supplements Market Size (2016-2027)
9.2 Latin America Diabetes Supplements Market Size by Type
9.2.1 Latin America Diabetes Supplements Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Supplements Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Supplements Market Size by Type (2016-2027)
9.3 Latin America Diabetes Supplements Market Size by Distribution Channel
9.3.1 Latin America Diabetes Supplements Market Size by Distribution Channel (2016-2021)
9.3.2 Latin America Diabetes Supplements Market Size by Distribution Channel (2022-2027)
9.3.3 Latin America Diabetes Supplements Market Size by Distribution Channel (2016-2027)
9.4 Latin America Diabetes Supplements Market Size by Country
9.4.1 Latin America Diabetes Supplements Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Supplements Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Supplements Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Supplements Market Size by Type
10.2.1 Middle East & Africa Diabetes Supplements Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Supplements Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Supplements Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Supplements Market Size by Distribution Channel
10.3.1 Middle East & Africa Diabetes Supplements Market Size by Distribution Channel (2016-2021)
10.3.2 Middle East & Africa Diabetes Supplements Market Size by Distribution Channel (2022-2027)
10.3.3 Middle East & Africa Diabetes Supplements Market Size by Distribution Channel (2016-2027)
10.4 Middle East & Africa Diabetes Supplements Market Size by Country
10.4.1 Middle East & Africa Diabetes Supplements Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Supplements Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Diabetes Supplements Introduction
11.1.4 Novo Nordisk Revenue in Diabetes Supplements Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 Nestlé Health Science
11.2.1 Nestlé Health Science Company Details
11.2.2 Nestlé Health Science Business Overview
11.2.3 Nestlé Health Science Diabetes Supplements Introduction
11.2.4 Nestlé Health Science Revenue in Diabetes Supplements Business (2016-2021)
11.2.5 Nestlé Health Science Recent Development
11.3 Danone Nutricia
11.3.1 Danone Nutricia Company Details
11.3.2 Danone Nutricia Business Overview
11.3.3 Danone Nutricia Diabetes Supplements Introduction
11.3.4 Danone Nutricia Revenue in Diabetes Supplements Business (2016-2021)
11.3.5 Danone Nutricia Recent Development
11.4 NaturoGain
11.4.1 NaturoGain Company Details
11.4.2 NaturoGain Business Overview
11.4.3 NaturoGain Diabetes Supplements Introduction
11.4.4 NaturoGain Revenue in Diabetes Supplements Business (2016-2021)
11.4.5 NaturoGain Recent Development
11.5 Nature’s Sunshine Forms
11.5.1 Nature’s Sunshine Forms Company Details
11.5.2 Nature’s Sunshine Forms Business Overview
11.5.3 Nature’s Sunshine Forms Diabetes Supplements Introduction
11.5.4 Nature’s Sunshine Forms Revenue in Diabetes Supplements Business (2016-2021)
11.5.5 Nature’s Sunshine Forms Recent Development
11.6 Nature’s Bounty
11.6.1 Nature’s Bounty Company Details
11.6.2 Nature’s Bounty Business Overview
11.6.3 Nature’s Bounty Diabetes Supplements Introduction
11.6.4 Nature’s Bounty Revenue in Diabetes Supplements Business (2016-2021)
11.6.5 Nature’s Bounty Recent Development
11.7 Glucose Health, Inc
11.7.1 Glucose Health, Inc Company Details
11.7.2 Glucose Health, Inc Business Overview
11.7.3 Glucose Health, Inc Diabetes Supplements Introduction
11.7.4 Glucose Health, Inc Revenue in Diabetes Supplements Business (2016-2021)
11.7.5 Glucose Health, Inc Recent Development
11.8 Unilever(Horlicks Cardia +)
11.8.1 Unilever(Horlicks Cardia +) Company Details
11.8.2 Unilever(Horlicks Cardia +) Business Overview
11.8.3 Unilever(Horlicks Cardia +) Diabetes Supplements Introduction
11.8.4 Unilever(Horlicks Cardia +) Revenue in Diabetes Supplements Business (2016-2021)
11.8.5 Unilever(Horlicks Cardia +) Recent Development
11.9 Bionova Lifesciences
11.9.1 Bionova Lifesciences Company Details
11.9.2 Bionova Lifesciences Business Overview
11.9.3 Bionova Lifesciences Diabetes Supplements Introduction
11.9.4 Bionova Lifesciences Revenue in Diabetes Supplements Business (2016-2021)
11.9.5 Bionova Lifesciences Recent Development
11.10 Caelus Health
11.10.1 Caelus Health Company Details
11.10.2 Caelus Health Business Overview
11.10.3 Caelus Health Diabetes Supplements Introduction
11.10.4 Caelus Health Revenue in Diabetes Supplements Business (2016-2021)
11.10.5 Caelus Health Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Diabetes Supplements Introduction
11.11.4 Abbott Revenue in Diabetes Supplements Business (2016-2021)
11.11.5 Abbott Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Diabetes Supplements Introduction
11.12.4 Pfizer Revenue in Diabetes Supplements Business (2016-2021)
11.12.5 Pfizer Recent Development
11.13 Arkopharma Laboratories
11.13.1 Arkopharma Laboratories Company Details
11.13.2 Arkopharma Laboratories Business Overview
11.13.3 Arkopharma Laboratories Diabetes Supplements Introduction
11.13.4 Arkopharma Laboratories Revenue in Diabetes Supplements Business (2016-2021)
11.13.5 Arkopharma Laboratories Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Diabetes Supplements Introduction
11.14.4 GlaxoSmithKline Revenue in Diabetes Supplements Business (2016-2021)
11.14.5 GlaxoSmithKline Recent Development
11.15 Archer Daniels Midland
11.15.1 Archer Daniels Midland Company Details
11.15.2 Archer Daniels Midland Business Overview
11.15.3 Archer Daniels Midland Diabetes Supplements Introduction
11.15.4 Archer Daniels Midland Revenue in Diabetes Supplements Business (2016-2021)
11.15.5 Archer Daniels Midland Recent Development
11.16 Herbalife International
11.16.1 Herbalife International Company Details
11.16.2 Herbalife International Business Overview
11.16.3 Herbalife International Diabetes Supplements Introduction
11.16.4 Herbalife International Revenue in Diabetes Supplements Business (2016-2021)
11.16.5 Herbalife International Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Diabetes Supplements Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vitamins
Table 3. Key Players of Minerals
Table 4. Key Players of Herbs
Table 5. Key Players of Proteins
Table 6. Key Players of Dietary Fibers
Table 7. Key Players of Others
Table 8. Global Diabetes Supplements Market Size Growth by Distribution Channel (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Diabetes Supplements Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Diabetes Supplements Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Diabetes Supplements Market Share by Regions (2016-2021)
Table 12. Global Diabetes Supplements Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Diabetes Supplements Market Share by Regions (2022-2027)
Table 14. Diabetes Supplements Market Trends
Table 15. Diabetes Supplements Market Drivers
Table 16. Diabetes Supplements Market Challenges
Table 17. Diabetes Supplements Market Restraints
Table 18. Global Diabetes Supplements Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Diabetes Supplements Market Share by Players (2016-2021)
Table 20. Global Top Diabetes Supplements Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Supplements as of 2020)
Table 21. Ranking of Global Top Diabetes Supplements Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Diabetes Supplements Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Diabetes Supplements Product Solution and Service
Table 25. Date of Enter into Diabetes Supplements Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Diabetes Supplements Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Diabetes Supplements Revenue Market Share by Type (2016-2021)
Table 29. Global Diabetes Supplements Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Diabetes Supplements Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Diabetes Supplements Market Size Share by Distribution Channel (2016-2021) & (US$ Million)
Table 32. Global Diabetes Supplements Revenue Market Share by Distribution Channel (2016-2021)
Table 33. Global Diabetes Supplements Forecasted Market Size by Distribution Channel (2022-2027) (US$ Million)
Table 34. Global Diabetes Supplements Revenue Market Share by Distribution Channel (2022-2027) & (US$ Million)
Table 35. North America Diabetes Supplements Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Diabetes Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Diabetes Supplements Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 38. North America Diabetes Supplements Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 39. North America Diabetes Supplements Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Diabetes Supplements Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Diabetes Supplements Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Diabetes Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Diabetes Supplements Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 44. Europe Diabetes Supplements Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 45. Europe Diabetes Supplements Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Diabetes Supplements Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetes Supplements Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Diabetes Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Diabetes Supplements Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 50. Asia-Pacific Diabetes Supplements Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Diabetes Supplements Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Diabetes Supplements Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Diabetes Supplements Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Diabetes Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Diabetes Supplements Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 56. Latin America Diabetes Supplements Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 57. Latin America Diabetes Supplements Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Diabetes Supplements Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetes Supplements Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Diabetes Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Diabetes Supplements Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 62. Middle East & Africa Diabetes Supplements Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Diabetes Supplements Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Diabetes Supplements Market Size by Country (2022-2027) & (US$ Million)
Table 65. Novo Nordisk Company Details
Table 66. Novo Nordisk Business Overview
Table 67. Novo Nordisk Diabetes Supplements Product
Table 68. Novo Nordisk Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 69. Novo Nordisk Recent Development
Table 70. Nestlé Health Science Company Details
Table 71. Nestlé Health Science Business Overview
Table 72. Nestlé Health Science Diabetes Supplements Product
Table 73. Nestlé Health Science Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 74. Nestlé Health Science Recent Development
Table 75. Danone Nutricia Company Details
Table 76. Danone Nutricia Business Overview
Table 77. Danone Nutricia Diabetes Supplements Product
Table 78. Danone Nutricia Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 79. Danone Nutricia Recent Development
Table 80. NaturoGain Company Details
Table 81. NaturoGain Business Overview
Table 82. NaturoGain Diabetes Supplements Product
Table 83. NaturoGain Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 84. NaturoGain Recent Development
Table 85. Nature's Sunshine Forms Company Details
Table 86. Nature's Sunshine Forms Business Overview
Table 87. Nature's Sunshine Forms Diabetes Supplements Product
Table 88. Nature's Sunshine Forms Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 89. Nature's Sunshine Forms Recent Development
Table 90. Nature's Bounty Company Details
Table 91. Nature's Bounty Business Overview
Table 92. Nature's Bounty Diabetes Supplements Product
Table 93. Nature's Bounty Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 94. Nature's Bounty Recent Development
Table 95. Glucose Health, Inc Company Details
Table 96. Glucose Health, Inc Business Overview
Table 97. Glucose Health, Inc Diabetes Supplements Product
Table 98. Glucose Health, Inc Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 99. Glucose Health, Inc Recent Development
Table 100. Unilever(Horlicks Cardia +) Company Details
Table 101. Unilever(Horlicks Cardia +) Business Overview
Table 102. Unilever(Horlicks Cardia +) Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 103. Unilever(Horlicks Cardia +) Recent Development
Table 104. Bionova Lifesciences Company Details
Table 105. Bionova Lifesciences Business Overview
Table 106. Bionova Lifesciences Diabetes Supplements Product
Table 107. Bionova Lifesciences Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 108. Bionova Lifesciences Recent Development
Table 109. Caelus Health Company Details
Table 110. Caelus Health Business Overview
Table 111. Caelus Health Diabetes Supplements Product
Table 112. Caelus Health Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 113. Caelus Health Recent Development
Table 114. Abbott Company Details
Table 115. Abbott Business Overview
Table 116. Abbott Diabetes Supplements Product
Table 117. Abbott Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 118. Abbott Recent Development
Table 119. Pfizer Company Details
Table 120. Pfizer Business Overview
Table 121. Pfizer Diabetes Supplements Product
Table 122. Pfizer Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 123. Pfizer Recent Development
Table 124. Arkopharma Laboratories Company Details
Table 125. Arkopharma Laboratories Business Overview
Table 126. Arkopharma Laboratories Diabetes Supplements Product
Table 127. Arkopharma Laboratories Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 128. Arkopharma Laboratories Recent Development
Table 129. GlaxoSmithKline Company Details
Table 130. GlaxoSmithKline Business Overview
Table 131. GlaxoSmithKline Diabetes Supplements Product
Table 132. GlaxoSmithKline Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 133. GlaxoSmithKline Recent Development
Table 134. Archer Daniels Midland Company Details
Table 135. Archer Daniels Midland Business Overview
Table 136. Archer Daniels Midland Diabetes Supplements Product
Table 137. Archer Daniels Midland Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 138. Archer Daniels Midland Recent Development
Table 139. Herbalife International Company Details
Table 140. Herbalife International Business Overview
Table 141. Herbalife International Diabetes Supplements Product
Table 142. Herbalife International Revenue in Diabetes Supplements Business (2016-2021) & (US$ Million)
Table 143. Herbalife International Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Supplements Market Share by Type: 2020 VS 2027
Figure 2. Vitamins Features
Figure 3. Minerals Features
Figure 4. Herbs Features
Figure 5. Proteins Features
Figure 6. Dietary Fibers Features
Figure 7. Others Features
Figure 8. Global Diabetes Supplements Market Share by Distribution Channel: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Diabetes Supplements Report Years Considered
Figure 13. Global Diabetes Supplements Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Diabetes Supplements Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Diabetes Supplements Market Share by Regions: 2020 VS 2027
Figure 16. Global Diabetes Supplements Market Share by Regions (2022-2027)
Figure 17. Global Diabetes Supplements Market Share by Players in 2020
Figure 18. Global Top Diabetes Supplements Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Supplements as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Diabetes Supplements Revenue in 2020
Figure 20. Global Diabetes Supplements Revenue Market Share by Type (2016-2021)
Figure 21. Global Diabetes Supplements Revenue Market Share by Type (2022-2027)
Figure 22. North America Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Diabetes Supplements Market Share by Type (2016-2027)
Figure 24. North America Diabetes Supplements Market Share by Distribution Channel (2016-2027)
Figure 25. North America Diabetes Supplements Market Share by Country (2016-2027)
Figure 26. United States Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Diabetes Supplements Market Share by Type (2016-2027)
Figure 30. Europe Diabetes Supplements Market Share by Distribution Channel (2016-2027)
Figure 31. Europe Diabetes Supplements Market Share by Country (2016-2027)
Figure 32. Germany Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Diabetes Supplements Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Diabetes Supplements Market Share by Distribution Channel (2016-2027)
Figure 41. Asia-Pacific Diabetes Supplements Market Share by Region (2016-2027)
Figure 42. China Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Diabetes Supplements Market Share by Type (2016-2027)
Figure 50. Latin America Diabetes Supplements Market Share by Distribution Channel (2016-2027)
Figure 51. Latin America Diabetes Supplements Market Share by Country (2016-2027)
Figure 52. Mexico Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Diabetes Supplements Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Diabetes Supplements Market Share by Distribution Channel (2016-2027)
Figure 57. Middle East & Africa Diabetes Supplements Market Share by Country (2016-2027)
Figure 58. Turkey Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Diabetes Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Novo Nordisk Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 62. Nestlé Health Science Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 63. Danone Nutricia Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 64. NaturoGain Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 65. Nature's Sunshine Forms Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 66. Nature's Bounty Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 67. Glucose Health, Inc Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 68. Unilever(Horlicks Cardia +) Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 69. Bionova Lifesciences Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 70. Caelus Health Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 71. Abbott Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 72. Pfizer Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 73. Arkopharma Laboratories Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 74. GlaxoSmithKline Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 75. Archer Daniels Midland Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 76. Herbalife International Revenue Growth Rate in Diabetes Supplements Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…- 世界の糖尿病栄養市場規模・現状・予測（2021年-2027年） Diabetes nutrition products are dietary products that contain less sugar and carbohydrate content. Market Analysis and Insights: Global Diabetes Nutrition Market The global Diabetes Nutrition market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% duri…
- 世界の妊娠糖尿病治療市場規模・現状・予測（2021年-2027年） Gestational diabetes can be defined as a type of diabetes that affects pregnant women. It is usually a temporary condition which develops during pregnancy and subsides after the birth of the baby. However, there are possibilities that diabetes may return in the later stages of life as type II diabet…
- 世界のサルコペニア治療サプリメント市場規模・現状・予測（2021年-2027年） There is no approved treatment option available for sarcopenia treatment but nutrition and dietary supplements have a key role in sarcopenia treatment.Major Sarcopenia treatment supplement comprises of protein, amino acids, creatine, omega 3 acid, vitamin D and B12, calcium carbonate. Nutrition prev…
- 世界の調剤薬局市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Compounding Pharmacies Market The global Compounding Pharmacies market size is projected to reach US$ 13500 million by 2027, from US$ 11180 million in 2020, at a CAGR of 2.7% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, t…